top of page

$2.6 Million Orthotics & Prosthetics Company located in New Jersey

Listing Code:



New Jersey


Orthotics & Prosthetics

Asking Price:




American HealthCare Capital is pleased to introduce a profitable, multi-location orthotics and prosthetics company based in Central New Jersey. The company was founded by its owner in 1996 and has an outstanding reputation for individualized patient care and providing the most advanced technological products. This well-regarded company provides customized, complex orthotic and prosthetic patient care. The company’s payers consist of Medicare, Medicaid, and Private Insurance, as well as direct business with area hospitals. The company has recently experienced impressive growth, which it has sustained. Revenues for 2019 and 2018 were approximately $3 million each year. The company experienced a downturn in 2021 and 2020 due to covered, with Revenues $2.6 million and $2.63 million respectively. The company is on track to return to pre-pandemic levels in 2022. All staff, including the owner, are expected to stay on under new ownership. The owner would like to work with a new owner that has the infrastructure to take advantage of the many significant growth opportunities. The asking price for this opportunity is $2.75 million.

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.


2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:


Listing Title:

$2.6 Million Orthotics & Prosthetics Company located in New Jersey

Heading 4

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi


American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings.

Thanks for submitting!

bottom of page